Study to Access Anti-CD38 Anibody Drug in Patients With Advanced Solid Tumors
Clinical trial NCT05584709 · UNKNOWN
Trial details
- NCT number
- NCT05584709
- Sponsor
- Sorrento Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-08-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.